Source:http://linkedlifedata.com/resource/pubmed/id/12560351
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-1-31
|
pubmed:abstractText |
Assays to screen for and confirm the presence of the antibody for human T-lymphotropic virus type I (HTLV-I) are currently performed with serum or plasma. We developed and evaluated a new counting immunoassay (CIA) for the detection of HTLV-I antibody in whole blood, using recombinant and synthetic peptide antigens.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Detection of anti-human T-lymphotropic virus type I antibody in whole blood by a novel counting immunoassay.
|
pubmed:affiliation |
Blood Transfusion Service, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto 860-8556, Japan. kyama@gpo.kumamoto-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|